HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA ‘Actively Investigating’ Asbestos In Cosmetics; Claire’s Rebuts New Allegations

This article was originally published in The Rose Sheet

Executive Summary

Health Canada’s investigation cleared Claire’s makeup previously linked to asbestos by Scientific Analytical Institute, the same lab whose asbestos findings Tween Brands disputed last year before launching a recall based on its own testing. Cosmetics manufacturers using talc should try to keep up.


Related Content

J&J Doing Damage Control Following Reuters Report On Asbestos ‘Lurking’ In Johnson’s Powder
FDA Shopping For 3D Tissue Bioprinter, Cosmetic Contamination Testing Services
Cosmetic Talc Under Scrutiny As Liability Buzzards Circle
‘Asbestos-Free’ A Relative Term? SAI Testing Expert On Cosmetic Talc Challenges
House Bill Seeks Asbestos Warnings On Unverified Kids' Cosmetics With Talc
Claire's Scare Revives Concerns About Asbestos-Tainted Kids' Cosmetics
Rep. Pallone Seeks Answers In Tween Makeup Asbestos Controversy
FDA: No Asbestos Found In Talc Products Sampled, But Results Limited





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts